Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Retinal Vasculitis Secondary to Durvalumab

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      2020
    • Collection:
      Universitat Autònoma de Barcelona: Dipòsit Digital de Documents de la UAB
    • نبذة مختصرة :
      Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, the retinal vasculitis resolved and macular edema improved during follow-up. There was no need for durvalumab to be withdrawn.
    • File Description:
      application/pdf
    • ISSN:
      16632699
    • Relation:
      Case Reports in Ophthalmology; Vol. 11 (may 2020), p. 161-166; https://ddd.uab.cat/record/227810; urn:10.1159/000507609; urn:oai:ddd.uab.cat:227810; urn:pmid:32508622; urn:pmcid:PMC7250381; urn:pmc-uid:7250381; urn:articleid:16632699v11p161; urn:oai:pubmedcentral.nih.gov:7250381; urn:oai:egreta.uab.cat:publications/479d2d58-e2bc-46a8-896d-d8def97a2d7e
    • الدخول الالكتروني :
      https://ddd.uab.cat/record/227810
    • Rights:
      open access ; Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. ; https://creativecommons.org/licenses/by-nc/4.0/
    • الرقم المعرف:
      edsbas.30ABD2D9